Results
3043
Most Popular Stocks on the market
3043 companies
Enimmune
Market Cap: NT$1.5b
Operates as a biopharmaceutical Research and development, and marketing company in Taiwan.
6564
NT$21.20
7D
2.4%
1Y
-37.6%
Albert David
Market Cap: ₹4.4b
Manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally.
524075
₹782.70
7D
-2.3%
1Y
-45.8%
FullHope BiomedicalLtd
Market Cap: NT$1.5b
Engages in the research and development of immune system-related services.
7773
NT$38.20
7D
-1.4%
1Y
-44.8%
ACC Aviation Holdings
Market Cap: US$49.9m
Focuses on developing canna powder products.
CAVG
US$0.10
7D
0%
1Y
-88.7%
Quratis
Market Cap: ₩69.9b
Engages in developing vaccines in South Korea.
A348080
₩947.00
7D
-5.8%
1Y
4.3%
Navana Pharmaceuticals
Market Cap: ৳6.1b
Engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh.
NAVANAPHAR
৳56.50
7D
0.2%
1Y
9.7%
Holy Stone Healthcare
Market Cap: NT$1.5b
Develops and sells hyaluronic acid related therapeutic products.
4194
NT$10.40
7D
2.0%
1Y
-39.9%
FibroGen
Market Cap: US$49.8m
A biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.
FGEN
US$12.31
7D
0.7%
1Y
23.3%
Earth Science Tech
Market Cap: US$49.8m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.17
7D
-8.1%
1Y
3.0%
Vivoryon Therapeutics
Market Cap: €42.5m
Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.
VVY
€1.62
7D
-3.0%
1Y
-45.9%
Sinil Pharmaceutical
Market Cap: ₩69.6b
Manufactures and sells pharmaceutical products in South Korea and internationally.
A012790
₩6,150.00
7D
-2.4%
1Y
-16.1%
Barinthus Biotherapeutics
Market Cap: US$49.7m
A clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases.
BRNS
US$1.22
7D
10.4%
1Y
2.5%
Guard Therapeutics International
Market Cap: SEK 461.8m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 22.90
7D
-3.0%
1Y
-18.2%
Sareum Holdings
Market Cap: UK£36.6m
A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.
SAR
UK£0.27
7D
-1.9%
1Y
0%
Jin Yang Pharmaceutical
Market Cap: ₩68.2b
Engages in the pharmaceutical business in South Korea.
A007370
₩5,750.00
7D
-3.4%
1Y
8.3%
iAnthus Capital Holdings
Market Cap: CA$67.8m
Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.
IAN
CA$0.01
7D
0%
1Y
0%
Sona Nanotech
Market Cap: CA$67.7m
Operates as a nanotechnology life sciences company.
SONA
CA$0.60
7D
-1.6%
1Y
122.2%
Ark Solutions
Market Cap: ₩68.9b
Engages in the research and development of products using protein in South Korea, Japan, Mexico, and internationally.
A203690
₩4,425.00
7D
0%
1Y
-63.6%
GENINUS
Market Cap: ₩67.9b
A bioinformation analysis company, engages in the research and development, manufacture, and sale of next generation sequencing (NGS) - based genome analysis solutions in South Korea.
A389030
₩2,090.00
7D
4.5%
1Y
31.5%
ORIENT BIO
Market Cap: ₩67.8b
Operates in the bio-industry in South Korea.
A002630
₩584.00
7D
-1.4%
1Y
26.1%
Kadimastem
Market Cap: ₪162.3m
A biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases.
KDST
₪34.90
7D
19.2%
1Y
375.9%
Cannabist Company Holdings
Market Cap: US$48.4m
The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally.
CBST.F
US$0.097
7D
-11.1%
1Y
-58.7%
Lantern Pharma
Market Cap: US$48.1m
Focuses on the discovery and development of oncology drug.
LTRN
US$4.46
7D
7.1%
1Y
21.4%
Lytix Biopharma
Market Cap: NOK 477.8m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 7.00
7D
1.4%
1Y
14.4%
PDS Biotechnology
Market Cap: US$48.0m
A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies.
PDSB
US$1.02
7D
-5.6%
1Y
-73.3%
TMS
Market Cap: JP¥7.1b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥158.00
7D
-3.7%
1Y
-17.3%
Yuyu Pharma
Market Cap: ₩66.9b
Develops and markets pharmaceutical products.
A000220
₩4,270.00
7D
-2.0%
1Y
-7.2%
Rafael Holdings
Market Cap: US$47.7m
Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel.
RFL
US$1.36
7D
-9.9%
1Y
-29.9%
Genetics Generation Advancement
Market Cap: NT$1.4b
Provides genetic testing and informatics services in Taiwan.
4160
NT$54.20
7D
1.7%
1Y
-40.8%
Inotiv
Market Cap: US$47.4m
Provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.
NOTV
US$1.38
7D
-1.4%
1Y
-18.8%
October PharmaE
Market Cap: ج.م2.3b
Manufactures and sells pharmaceutical products in Egypt.
OCPH
ج.م189.32
7D
1.0%
1Y
54.3%
Kim Forest Enterprise
Market Cap: NT$1.4b
Provides various genetic and medical testing services in China and the United States.
6645
NT$23.60
7D
1.3%
1Y
-17.9%
Telomir Pharmaceuticals
Market Cap: US$47.0m
A preclinical-stage biotechnology company, focuses on reversing biological aging and degenerative diseases.
TELO
US$1.39
7D
-10.9%
1Y
-78.3%
Bafna Pharmaceuticals
Market Cap: ₹4.2b
Manufactures and sells finished pharmaceutical formulations in India.
BAFNAPH
₹172.80
7D
19.1%
1Y
103.3%
EyeGene
Market Cap: ₩65.1b
Engages in the research and development of biopharmaceutical drugs for the treatment and prevention of age-related diseases in South Korea.
A185490
₩2,435.00
7D
-6.3%
1Y
-20.0%
Tianda Pharmaceuticals
Market Cap: HK$361.2m
Engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia.
455
HK$0.17
7D
7.7%
1Y
-19.6%